(April 17, 2020 / JNS) Sens. Chris Coons (D-Del.) and Ted Cruz (R-Texas) announced on Thursday that they will seek to appropriate $12 million in upcoming legislation to enhance partnerships between companies in the United States and Israel to develop innovative medical projects aimed at detecting, treating and curing coronavirus.
“The United States and Israel are world leaders in the medical technology industry, and it is in the interest of all Americans, Israelis and the rest of the world that we work together to fight COVID-19,” said Coons. “This virus knows no borders, and our bill underscores the importance of international collaboration in the face of a truly global pandemic.”
“I’ve long said that China poses the most significant, long-term geopolitical threat to the United States. Our dependence on China for life-saving medications and treatments is deeply problematic,” said Cruz. “Israel is not only our friend and ally, but also a global leader in medicine with which we already cooperate on exactly those issues.”
The Conference of Presidents of Major Jewish Organizations applauded the development.
“The U.S. and Israel are among the most medically advanced countries in the world,” said the umbrella organization in a statement on Friday. “As the medical sectors of both nations race to develop methods to combat this pandemic, Americans and Israelis stand to benefit immensely by increased cooperation and collaboration.”
Congress is expected to pass a fourth piece of legislation to provide assistance in responding to the pandemic. Last month, Congress passed an unprecedented spending bill to provide $2.1 trillion in assistance to Americans and businesses affected by the outbreak.
Support Jewish Journalism
with 2020 Vision
One of the most intriguing stories of the sudden Coronavirus crisis is the role of the internet. With individuals forced into home quarantine, most are turning further online for information, education and social interaction.
JNS's influence and readership are growing exponentially, and our positioning sets us apart. Most Jewish media are advocating increasingly biased progressive political and social agendas. JNS is providing more and more readers with a welcome alternative and an ideological home.
During this crisis, JNS continues working overtime. We are being relied upon to tell the story of this crisis as it affects Israel and the global Jewish community, and explain the extraordinary political developments taking place in parallel.
Our ability to thrive in 2020 and beyond depends on the generosity of committed readers and supporters. Monthly donations in particular go a long way in helping us sustain our operations. We greatly appreciate any contributions you can make during these challenging times. We thank you for your ongoing support and wish you blessings for good health and peace of mind.